Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Blue Owl Capital will acquire health care-focused REIT Sila Realty Trust in a deal valued at $2.4 billion. Blue Owl affiliates will buy Sila Realty Trust and absorb its 137 developed properties nationwide.
The acquisition price corresponds to $30.38 per share, implying a 19% premium to Sila Realty Trust’s stock price at Friday’s close. The announcement triggered a 20% surge in Sila’s share price at market open. The transaction is positioned as a scaled portfolio purchase with durable cash flows.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026